Beneficial Ownership Report · SCHEDULE 13G/A
Freenome, Inc.
FRNMNASDAQEQUITYCurrent
Beneficial Ownership Report
Structured filing — SCHEDULE 13G/A
primary_doc.xml
Amendment · This filing reports the amendment as submitted.
Subject company
- Company
- Freenome, Inc.
- Company CIK
- 0002017526
- Street
- GENESIS MARINA, 3300 MARINA BLVD
- City
- BRISBANE
- State / country code
- CA
- Postal code
- 94005
Statement details
- Amendment number
- 1
- Security class
- Common Stock, par value $0.0001 per share
- Event date
- 09/30/2026
- Rule designation
- Rule 13d-1(b)
Reporting person 1
- Name
- Aberdeen Group plc
- Citizenship / organization
- X0
- Reporting person type
- HC
- Aggregate amount owned
- 656,676
- Percent of class
- 0.61
- Sole voting power
- 0
- Shared voting power
- 656,676
- Sole dispositive power
- 0
- Shared dispositive power
- 656,676
- Aggregate excludes certain shares
- N
Reporting person 2
- Name
- abrdn Inc.
- Citizenship / organization
- X1
- Reporting person type
- CO · IA
- Aggregate amount owned
- 656,676
- Percent of class
- 0.61
- Sole voting power
- 0
- Shared voting power
- 656,676
- Sole dispositive power
- 0
- Shared dispositive power
- 656,676
- Aggregate excludes certain shares
- N
Item 1
Issuer
Freenome, Inc.
Principal executive office address
GENESIS MARINA, 3300 MARINA BLVD, BRISBANE, CALIFORNIA 94005
Item 2
Citizenship
Aberdeen Group plc - UNITED KINGDOM abrdn Inc. - UNITED STATES
Filing person
Aberdeen Group plc abrdn Inc.
Principal business or residence address
Aberdeen Group plc 1 George Street Edinburgh, United Kingdom EH2 2LL abrdn inc 1900 Market Street Suite 200. Philadelphia, PA 19103
Item 3
Not applicable indication
N
Type of filing person
HC
Item 4
Percent of class
0.61
Amount beneficially owned
656,676
Sole voting power
Aberdeen Group plc - 0 abrdn Inc. - 0
Shared voting power
Aberdeen Group plc - 656,676 abrdn Inc. - 656,676
Sole dispositive power
Aberdeen Group plc - 0 abrdn Inc. - 0
Shared dispositive power
Aberdeen Group plc - 656,676 abrdn Inc. - 656,676
Item 5
Not applicable indication
N
Ownership of 5% or less
Y
Item 6
Not applicable indication
Y
Item 7
Not applicable indication
N
Subsidiaries
See Exhibit
Item 8
Not applicable indication
Y
Item 9
Not applicable indication
Y
Item 10
Not applicable indication
N
Certifications
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Exhibits
Aberdeen Group plc abrdn Holdings Limited abrdn Inc. Aberdeen Group plc is the parent company. abrdn Holdings Limited is the intermediate holding company for abrdn Inc. abrdn Inc. beneficially owns on behalf of our underlying clients less than 5% the outstanding shares of the security class being reported on this Schedule 13G.
Signature 1
- Reporting person
- Aberdeen Group plc
- Signed
- Cara Bird
- Title
- Cara Bird/Major Shareholding Reporting Analyst
- Date
- 10/29/2026
Signature 2
- Reporting person
- abrdn Inc.
- Signed
- Cara Bird
- Title
- Cara Bird/Major Shareholding Reporting Analyst
- Date
- 10/29/2026
Company context
Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company’s proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome’s development of SimpleScreen™ CRC for colorectal cancer screening and a pipeline of tests for lung cancer and additional indications is designed to increase cancer detection among millions of at-risk individuals. For more information, visit www.freenome.com.